Regulation of HIV-1 Latency via SMYD2-Mediated Histone Methylation

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantitative Profiling of the Activity of Protein Lysine Methyltransferase SMYD2 Using SILAC-Based Proteomics*

  2016cited by this paper
• The Latent Reservoir for HIV-1: How Immunologic Memory and Clonal Expansion Contribute to HIV-1 Persistence

  2016cited by this paper
• Reversal of Latency as Part of a Cure for HIV-1.

  2016cited by this paper
• Loss of HP1 causes depletion of H3K27me3 from facultative heterochromatin and gain of H3K27me2 at constitutive heterochromatin

  2016cited by this paper
• Targeting histone methylation for cancer therapy: enzymes, inhibitors, biological activity and perspectives

  2016cited by this paper
• Smyd2 is a Myc-regulated gene critical for MLL-AF9 induced leukemogenesis

  2016cited by this paper
• Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations.

  2015cited by this paper
• Histone H4 Lysine 20 (H4K20) Methylation, Expanding the Signaling Potential of the Proteome One Methyl Moiety at a Time*

  2015cited by this paper
• Critical roles of non-histone protein lysine methylation in human tumorigenesis

  2015cited by this paper
• Transcriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cure.

  2014cited by this paper
• The histone methyltransferase SMYD2 methylates PARP1 and promotes poly(ADP-ribosyl)ation activity in cancer cells.

  2014cited by this paper
• Emerging strategies to deplete the HIV reservoir

  2014cited by this paper
• An In-Depth Comparison of Latent HIV-1 Reactivation in Multiple Cell Model Systems and Resting CD4+ T Cells from Aviremic Patients

  2013cited by this paper
• Readout of epigenetic modifications.

  2013cited by this paper
• Acetylation of RNA polymerase II regulates growth-factor-induced gene transcription in mammalian cells.

  2013cited by this paper
• RB1 methylation by SMYD2 enhances cell cycle progression through an increase of RB1 phosphorylation.

  2012cited by this paper
• Structure–activity relationships of methyl-lysine reader antagonists

  2012cited by this paper
• Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy

  2012cited by this paper
• HIV: Shock and kill

  2012cited by this paper
• PR-Set7 and H4K20me1: at the crossroads of genome integrity, cell cycle, chromosome condensation, and transcription.

  2012cited by this paper
• Structural basis of substrate methylation and inhibition of SMYD2.

  2011cited by this paper
• Proteomic analyses of the SMYD family interactomes identify HSP90 as a novel target for SMYD2.

  2011cited by this paper
• The control of HIV transcription: keeping RNA polymerase II on track.

  2011cited by this paper
• The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.

  2011cited by this paper
• Epigenetic Silencing of HIV-1 by the Histone H3 Lysine 27 Methyltransferase Enhancer of Zeste 2

  2011cited by this paper
• BET bromodomain inhibition as a therapeutic strategy to target c-Myc.

  2011cited by this paper
• Repressive LTR Nucleosome Positioning by the BAF Complex Is Required for HIV Latency

  2011cited by this paper
• Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification.

  2011cited by this paper
• L3MBTL2 protein acts in concert with PcG protein-mediated monoubiquitination of H2A to establish a repressive chromatin structure.

  2011cited by this paper
• MBT domain proteins in development and disease.

  2010cited by this paper
• Selective inhibition of BET bromodomains

  2010cited by this paper
• The Cellular lysine methyltransferase Set7/9-KMT7 binds HIV-1 TAR RNA, monomethylates the viral transactivator Tat, and enhances HIV transcription.

  2010cited by this paper
• Chromatin dynamics associated with HIV-1 Tat-activated transcription.

  2010cited by this paper
• Methylation of the Retinoblastoma Tumor Suppressor by SMYD2*

  2010cited by this paper
• Involvement of Histone H3 Lysine 9 (H3K9) Methyltransferase G9a in the Maintenance of HIV-1 Latency and Its Reactivation by BIX01294*

  2010cited by this paper
• Suppression of inflammation by a synthetic histone mimic

  2010cited by this paper
• Monomethylation of Histone H4-Lysine 20 Is Involved in Chromosome Structure and Stability and Is Essential for Mouse Development

  2009cited by this paper
• MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification

  2008influential reference
• A chromatin-wide transition to H4K20 monomethylation impairs genome integrity and programmed DNA rearrangements in the mouse.

  2008cited by this paper
• Histone H4 lysine 20 monomethylation promotes transcriptional repression by L3MBTL1

  2008cited by this paper
• L3MBTL1 recognition of mono- and dimethylated histones

  2007cited by this paper
• L3MBTL1, a histone-methylation-dependent chromatin lock.

  2007cited by this paper
• Certain and Progressive Methylation of Histone H4 at Lysine 20 during the Cell Cycle

  2007cited by this paper
• Repression of p53 activity by Smyd2-mediated methylation

  2006cited by this paper
• Chromatin Compaction by a Polycomb Group Protein Complex

  2004cited by this paper
• A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin.

  2004cited by this paper
• HIV reproducibly establishes a latent infection after acute infection of T cells in vitro

  2003cited by this paper
• Acetylation of Tat defines a cyclinT1-independent step in HIV transactivation.

  2003cited by this paper
• Direct and Quantitative Single-Cell Analysis of Human Immunodeficiency Virus Type 1 Reactivation from Latency

  2002cited by this paper
• PR-Set7 is a nucleosome-specific methyltransferase that modifies lysine 20 of histone H4 and is associated with silent chromatin.

  2002cited by this paper
• The site of HIV‐1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation

  2001cited by this paper
• Histone acetyltransferases regulate HIV-1 enhancer activity in vitro.

  1997cited by this paper
• In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector

  1996cited by this paper
• Transcriptional activation and chromatin remodeling of the HIV‐1 promoter in response to histone acetylation.

  1996cited by this paper
• Evidence that a cell cycle regulator, E2F1, down-regulates transcriptional activity of the human immunodeficiency virus type 1 promoter

  1995cited by this paper
• Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation.

  1993cited by this paper
• Bioinformatics Applications Note Gene Expression Skyline: an Open Source Document Editor for Creating and Analyzing Targeted Proteomics Experiments

  year unknowncited by this paper

• No citing papers are available for this paper.